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A 49-year-old male was referred to the hospital because of syncope caused by ventricular
tachycardia (VT) with a pulse of 240 bpm and QRS morphology with a LBBB conﬁguration
and superior axis. The patient had been on a long-term regimen of steroids to treat his
scleroderma. Satisfying 2 major criteria (QRS widening and an epsilon wave in the right chest
leads) and 3 minor criteria (a slight enlargement and akinesis of the right ventricle, positive
late potential in the signal averaged electrocardiogram and left bundle branch block-type VT)
he was diagnosed with arrhythmogenic right ventricular cardiomyopathy. A voltage map of
his right ventricle (RV) during sinus rhythm was obtained using an electroanatomical
mapping system (CARTO, Biosense-Webster, Diamond, CA, USA). Two islet-like low
voltage areas were found and linear double potentials were recognized between areas in the
lateral wall of the right ventricle (RV) very close to the tricuspid annulus. The earliest
activation of the double potential line during VT was 70msec prior to the QRS onset. We
applied radiofrequency energy at that point during the VT and it successfully slowed and
terminated the VT. Thereafter the VT could not be induced by any stimulation from multiple
RV sites.
(J Arrhythmia 2005; 21: 542–545)
Key words: Ventricular tachycardia, Scleroderma, Arrhythmogenic right ventricular cardiomyopathy
Case Report
The patient was a 49-year-old male. He had been
taking oral steroids since 1999 to treat scleroderma
(esophagitis and pulmonary ﬁbrosis). In August of
2004 he lost consciousness and was taken to the
emergency department of another hospital. The
surface electrocardiogram revealed a ventricular
tachycardia (VT) with a left bundle branch block
(LBBB) and superior axis at a rate of 240 bpm
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(Figure 1). A venous injection of 100mg of lidocaine
was ineﬀective, however, after a venous injection of
2mg of propranolol the patient’s tachycardia termi-
nated. A twelve-lead electrocardiogram recorded on
admission revealed a left axis shift with an incom-
plete right bundle branch block and epsilon wave
immediately following the QRS complex in lead, V2
(Figure 2). The echocardiography revealed moderate
enlargement of both ventricles (LVDd ¼ 59mm),
and hypokinesis of the entire left ventricle (EF ¼
30%, FS ¼ 14%), especially the posterior wall. The
signal averaged electrocardiogram exhibited positive
late potentials. From these ﬁnding arrhythmogenic
right ventricular cardiomyopathy was suspected.
Angiography did not show any signiﬁcant stenoses
in the left or right coronaries. Right ventriculography
showed a slight enlargement of the right ventricle
and slight hypokinesis (RVEDV ¼ 253ml, RVEF ¼
25%). Left ventriculography revealed hypokinesis of
the posterior wall and a slight hypokinesis in the
apical area (LVEDV ¼ 266ml, LVEF ¼ 51%). A
myocardial biopsy of the tissue taken from the septal
wall of the right ventricle was normal. Multi-detector
computed tomography (MDCT) revealed an enlarge-
ment of the right ventricle but no other abnormal-
ities, such as fatty degeneration.
Electrophysiological Study
From the morphology of the 12 lead electro-
cardiogram during the VT, we suspected that the VT
originated from the right ventricle. An electroana-
tomical mapping system (CARTO, Biosense-Web-
ster, Diamond Bar, CA, USA) was used to conduct
voltage mapping of the RV during sinus rhythm
since the patient’s vital signs were unstable and we
were unable to construct an activation map during
VT. Islets of low voltage were noted at the opposite
wall just under the tricuspid valve, and a linear
conﬁguration of double potential sites was found
between the islets (Figure 3). No VT was induced by
programmed stimulation from the right ventricular
apex during the baseline or after administering
isoproterenol. However, VT was induced with burst
stimulation conducted from the most electrically
fragmented part of the right ventricular wall. At this
site a satisfactory pace map was generated. On the
surface electrocardiogram taken during the VT, the
V wave preceded the QRS complex by 70msec, so
an attempt was made to ablate that site with a 4mm
tip Navistar (Biosense-Webster, Diamond Bar,
CA, USA). The current was delivered but the
temperature did not rise, so another attempt was
made with an 8mm tip, resulting in successfully
slowing the pulse and reversing the VT (Figure 3).
Thereafter, the VT could not be induced even under
an isoprotelenol infusion and thus, the treatment was
terminated.
Discussion
Scleroderma is a connective tissue disease in
which lesions and ﬁbrosis in the microvasculature
cause damage to the skin, esophagus and respiratory
system. Reports indicate that the heart is aﬀected in
about 25% of such patients.1) Clinical manifestations
include conduction defects, pericarditis, angina
pectoris and acute myocardial infarction, which are
sometimes conﬁrmed by post-sudden-death autop-
sy.2) In the present report we described a patient
undergoing treatment for scleroderma exhibiting
changes consistent with arrhythmogenic right ven-
tricular myocardosis. The patient satisﬁed 2 of the
major criteria (QRS widening and an epsilon wave in
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Figure 1 The 12-lead electrocardiogram paroxysmal VT.
A 12-lead surface electrocardiogram showed a ventricular tachy-
cardia (VT) with left bundle branch block (LBBB) and superior
axis at the rate of 240 bpm.
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the right chest leads) and 3 of the minor criteria
(slight enlargement and akinesis of the right ven-
tricle, a positive late potential in the signal averaged
electrocardiogram and a left bundle branch block-
type VT) of the criteria of scleroderma reported by
Mckenna WJ et al.3) There are some reports in the
literature of myocarditis-like changes with sclero-
derma as in the present case.4) The cardiac damage
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Figure 3
An electroanatomical mapping system was used to conduct voltage mapping of RV during sinus rhythm. Islets of low voltage were noted
at the opposite wall just under the tricuspid valve, and a linear conﬁguration of double potential sites were found between the islets (Right:
RAO view, Left: Right lateral view).
Figure 2 The 12-lead electrocardiogram at
absolute rest.
A 12-lead surface electrocardiogram at admis-
sion showed a left axis shift with an incomplete
right bundle branch block and an epsilon wave
immediately following the QRS complex in lead
V2.
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that occurs in scleroderma is considered to be a
result of reduced coronary perfusion, damage to
small vessels and ﬁbrosis.4,5) The involvement of the
right ventricle in scleroderma has been reported to be
the result of the RV dilatation following pulmonary
hypertension or a myocardial infarction due to
coronary vasospasms.4,5)
In the present case areas with islets of low-voltage
were measured in the voltage map from the right
ventricle taken from the lateral region just below the
tricuspid valve, and radiofrequency ablation was
successful at the fractionated potential sites between
the islets. Since the patient’s vital signs were
unstable, we were unable to create an activation
map during the VT, and were unable to verify the VT
circuit. There have been two cases reported in the
literature describing patients undergoing treatment
for scleroderma that developed VT that was veriﬁed
to have originated from the right ventricle by
electoranatomical mapping as in the present case.5)
In that report, RV septal scarring was associated with
a reentrant substrate in the ﬁrst case, and in the
second case, the LV and RV free walls close to the
tricuspid valve were associated with two clinical
VTs.
We experienced a case with arrhythmogenic right
ventricular myocarditis-like changes and VT under-
going treatment for scleroderma. We were successful
with radiofrequency ablation applications aimed at
fractionated potential sites just below the tricuspid
valve. Although we were able to successfully ablate
the origin of the VT, we decided it was better to
implant an ICD after the ablation since scleroderma
was a progressive disease. However, we were unable
to get the patient’s consent.
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Figure 4
The current was delivered during VT and resulting in successfully slowing the pulse and terminating the VT.
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